Ozempic for PCOS: Weight Loss, Hormone Balance, and Fertility Outcomes
Introduction: PCOS Meets GLP-1 Polycystic ovary syndrome (PCOS) affects an estimated 8–13% of reproductive-age women worldwide, making it the most common endocrine disorder in this population. At its core, PCOS is not just a reproductive condition — it is fundamentally a metabolic disorder. Insulin resistance sits at the center of the pathophysiology for the majority of women with PCOS, driving both the metabolic complications (weight gain, dyslipidemia, progression to type 2 diabetes) and the reproductive manifestations (hyperandrogenism, anovulation, infertility). ...